Progress report of the NIDA Addiction Research Center.
D000700:Analgesics / Q000494:pharmacology; D002047:Buprenorphine / Q000627:therapeutic use; D002707:Chlordiazepoxide / Q000494:pharmacology; D003000:Clonidine / Q000627:therapeutic use; D003975:Diazepam / Q000494:pharmacology; D006801:Humans; D009020:Morphine / Q000009:adverse effects; D009316:National Institutes of Health (U.S.); D013375:Substance Withdrawal Syndrome / Q000188:drug therapy; D019966:Substance-Related Disorders / Q000534:rehabilitation; D014029:Tobacco Use Disorder / Q000209:etiology; D014046:Tolmetin / Q000031:analogs & derivatives / Q000494:pharmacology; D014481:United States
D000700:Analgesics; D002047:Buprenorphine; D002707:Chlordiazepoxide; D009020:Morphine; C020549:zomepirac; D014046:Tolmetin; D003000:Clonidine; D003975:Diazepam